Sinovac Biotech Ltd (SVA) : Common share offering over-allotment

Feb 2, ’10 12:53 AM
Author iam802 Categories Healthcare Tags

A little bit of good news (and bad news) depending on the point of view.

1. SVA announced that the underwriters will be exercising their option to purchase an additional 1.5M common shares to cover over-allotments.

2. This is good news as there is demand for the shares.

3. The downside of course is the dilution.

4. So, where do we go from there. My bet is that the price will not fall much further. We should probably see some support coming.

Related posts:

  1. Sinovac Biotech Ltd (SVA) : Price still above Tenkan sen
  2. Sinovac Biotech Ltd (SVA) : On the move again.
  3. Sinovac Biotech Ltd. (SVA) : A Short Term Play on H1N1
  4. Sinovac Biotech Ltd (SVA) : Trailing Stop Triggered
  5. Sinovac Biotech Ltd (SVA) : Review of My SVA Trade
‹
›

Trackbacks

One Trackback
  1. February 11, 2010 Sinovac Biotech Ltd (SVA) : On the move again.

Add Your Comments

Required
Required
Tips

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <ol> <ul> <li> <strong>

Your email is never published nor shared.

Ready?